Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malvika Verma

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMJ Global Health|March 1, 2019
Making the case: developing innovative adherence solutions for the treatment of tuberculosisMalvika Verma, Jennifer Furin, Robert Langer, et al.
Nature Reviews. Drug Discovery|September 6, 2023
The next-generation CAR-T therapy landscapeMalvika Verma, Kyle Obergfell, Shana Topp, et al.
Nature Reviews. Drug Discovery|January 10, 2023
The landscape for lipid-nanoparticle-based genomic medicinesMalvika Verma, Imran Ozer, Wen Xie, et al.
Nature Nanotechnology|March 23, 2021
Nanotechnology approaches for global infectious diseasesAmeya R Kirtane, Malvika Verma, Paramesh Karandikar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting TreatmentsEthel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swineMalvika Verma, Jacqueline N Chu, John A F Salama, et al.
Science Translational Medicine|March 15, 2019
A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatmentMalvika Verma, Karan Vishwanath, Feyisope Eweje, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMJ Global Health|March 1, 2019
Making the case: developing innovative adherence solutions for the treatment of tuberculosisMalvika Verma, Jennifer Furin, Robert Langer, et al.
Nature Reviews. Drug Discovery|September 6, 2023
The next-generation CAR-T therapy landscapeMalvika Verma, Kyle Obergfell, Shana Topp, et al.
Nature Reviews. Drug Discovery|January 10, 2023
The landscape for lipid-nanoparticle-based genomic medicinesMalvika Verma, Imran Ozer, Wen Xie, et al.
Nature Nanotechnology|March 23, 2021
Nanotechnology approaches for global infectious diseasesAmeya R Kirtane, Malvika Verma, Paramesh Karandikar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting TreatmentsEthel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swineMalvika Verma, Jacqueline N Chu, John A F Salama, et al.
Science Translational Medicine|March 15, 2019
A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatmentMalvika Verma, Karan Vishwanath, Feyisope Eweje, et al.
Pageof 1